We offer a range of pharmaceutical bulk actives and intermediates in therapeutic categories of Central nervous system , Cardiovascular system , Gastro-intestinal and Anti-infectives.

	Patent non-infringing technologies
	State-of-the-art pilot and commercial scale multi-purpose
	Pharmaceutical manufacturing plants conforming to cGMP guidelines and approved by various regulatory authorities such as US FDA and TGA
	R&D facilities to support early development of generic APIs
	High quality documents - Drug Master Files

We have more than 45 products under different stages of development. The new product development is mainly focused on therapeutic categories of Central Nervous Systems , Cardiovascular system and Anti-diabetics. A dedicated team of more than 100 research scientists work in our state-of-the-art research centers at Noida and Nanjangud. These research facilities are equipped with latest scientific instruments.

API Business:

Vision: To achieve global leadership in all major product categories.